Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
| ▸ | RXRA | P19793 | 1/20 | 0.32 |
| ▸ | RXRG | P48443 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 6/20 | 0.32 |
| ▸ | ICMT | O60725 | 4/20 | 0.32 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20849353 | 0.96 | CYP11B1 (0.35) | CYP11B1CYP11B2RXRARXRGAR | |
| SCHEMBL20849053 | 0.95 | AR (0.35) | CYP11B1CYP11B2RXRARXRGAR | |
| SCHEMBL20849026 | 0.95 | AR (0.35) | CYP11B1CYP11B2ARICMT | |
| SCHEMBL21131417 | 0.94 | CYP11B1 (0.40) | CYP11B1CYP11B2RXRARXRGAR | |
| SCHEMBL20848982 | 0.94 | AR (0.36) | CYP11B1CYP11B2RXRAARICMT | |
| SCHEMBL20849054 | 0.94 | AR (0.43) | CYP11B1CYP11B2RXRARXRGAR | |
| SCHEMBL20848574 | 0.94 | NR3C1 (0.39) | CYP11B1CYP11B2ARICMT | |
| SCHEMBL20848533 | 0.94 | RXRA (0.34) | CYP11B1CYP11B2RXRARXRGAR | |
| SCHEMBL22985190 | 0.93 | ALOX5AP (0.39) | CYP11B1CYP11B2ARICMT | |
| SCHEMBL20849049 | 0.93 | AR (0.39) | CYP11B1CYP11B2RXRAAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10978646-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-04-13 | — | — | US | disclosed |
| US-20190097141-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10978646-B2 | Organic molecules for use in optoelectronic devices | OCIAD2, OCIAD1, POU2F1 | CYP11B1 2072/4885CYP11B2 2189/4885RXRA 1822/4885 |
| US-20190097141-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OCIAD2, OCIAD1, POU2F1 | CYP11B1 2072/4885CYP11B2 2189/4885RXRA 1822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.